FDA.reportPublic FDA data

risdiplam 5 MG Oral Tablet

RxCUI
2705365
RxNorm name
risdiplam 5 MG Oral Tablet
Display name
risdiplam 5 MG Oral Tablet
Full name
risdiplam 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eceb9a99-7191-4be5-87c3-0102707cf98erisdiplam 5 MG Oral Tablet [PSN] · risdiplam 5 MG Oral Tablet [SCD]226These highlights do not include all the information needed to use EVRYSDI safely and effectively. See full prescribing information for EVRYSDI. EVRYSDI ® (risdiplam) for oral solution EVRYSDI ® (risdiplam) tablets, for oral use Initial U.S. Approval: 202020260219